Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS. / Holland-Fischer, Peter; Grønbæk, Henning; Sandahl, Thomas Damgaard et al.
In: Gut, Vol. 60, No. 10, 10.2011, p. 1389-93.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
}
TY - JOUR
T1 - Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
AU - Holland-Fischer, Peter
AU - Grønbæk, Henning
AU - Sandahl, Thomas Damgaard
AU - Moestrup, Søren Kragh
AU - Riggio, Oliviero
AU - Ridola, Lorenzo
AU - Aagaard, Niels Kristian
AU - Møller, Holger Jon
AU - Vilstrup, Hendrik
PY - 2011/10
Y1 - 2011/10
N2 - Introduction Hepatic macrophages (Kupffer cells) undergo inflammatory activation during the development of portal hypertension in experimental cirrhosis; this activation may play a pathogenic role or be an epiphenomenon. Our objective was to study serum soluble CD163 (sCD163), a sensitive marker of macrophage activation, before and after reduction of portal venous pressure gradient by insertion of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with cirrhosis. Methods sCD163 was measured in 11 controls and 36 patients before and 1, 4 and 26 weeks after TIPS. We used lipopolysaccharide binding protein (LBP) levels as a marker of endotoxinaemia. Liver function and clinical status of the patients were assessed by galactose elimination capacity and Model for End Stage Liver Disease score. Results The sCD163 concentration was more than threefold higher in the patients than in the controls (median 5.22 mg/l vs 1.45 mg/l, p
AB - Introduction Hepatic macrophages (Kupffer cells) undergo inflammatory activation during the development of portal hypertension in experimental cirrhosis; this activation may play a pathogenic role or be an epiphenomenon. Our objective was to study serum soluble CD163 (sCD163), a sensitive marker of macrophage activation, before and after reduction of portal venous pressure gradient by insertion of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with cirrhosis. Methods sCD163 was measured in 11 controls and 36 patients before and 1, 4 and 26 weeks after TIPS. We used lipopolysaccharide binding protein (LBP) levels as a marker of endotoxinaemia. Liver function and clinical status of the patients were assessed by galactose elimination capacity and Model for End Stage Liver Disease score. Results The sCD163 concentration was more than threefold higher in the patients than in the controls (median 5.22 mg/l vs 1.45 mg/l, p
U2 - 10.1136/gut.2010.234542
DO - 10.1136/gut.2010.234542
M3 - Journal article
C2 - 21572121
VL - 60
SP - 1389
EP - 1393
JO - Gut
JF - Gut
SN - 0017-5749
IS - 10
ER -